LC-MS in analytical toxicology: Some practical considerations

Biomedical Chromatography

Volumn 25, Issue 1, 2011, Pages 100-123

  Couchman, Lewis ^a   Morgan, Phillip E ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Analytical toxicology; Liquid chromatography; Mass spectrometry; Sample preparation

Indexed keywords

ATMOSPHERIC IONIZATION; ATMOSPHERIC PRESSURE; LIQUID CHROMATOGRAPHY;

ANALYTES; ANALYTICAL TOXICOLOGY; ATMOSPHERIC PRESSURE IONIZATION; IONIZATION PROCESS; MASS ANALYSIS; MATRIX COMPONENTS; SAMPLE PREPARATION; SINGLE STAGE; TANDEM MASS SPECTROMETRY; TANDEM-MASS SPECTROMETRY;

MASS SPECTROMETRY;

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 7 AMINO 1,3 DIHYDRO 5 PHENYL 2H 1,4 BENZODIAZEPIN 2 ONE; ACEBUTOLOL; AMFEBUTAMONE; AMPHETAMINE; BENZOYLECGONINE; BROTIZOLAM; CENTRAL STIMULANT AGENT; COCAINE; CODEINE; DIHYDROCODEINE; DIURETIC AGENT; ETIZOLAM; KETAMINE; LABETALOL; LORAZEPAM; METHADONE; METHAMPHETAMINE; METOPROLOL; MORPHINE; NITRAZEPAM; NORDAZEPAM; OPIATE; PHENETHYLAMINE; PIPERAZINE DERIVATIVE; PROPRANOLOL; RADAFAXINE; TEMAZEPAM; UNINDEXED DRUG;

ACCREDITATION; ATMOSPHERIC PRESSURE; BLOOD ANALYSIS; BREAST MILK; ELECTROSPRAY; HAIR ANALYSIS; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETER; MASS SPECTROMETRY; PLASMA; PRECIPITATION; REVIEW; SEROLOGY; SOLID PHASE EXTRACTION; URINALYSIS;

EID: 78650666190     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1566     Document Type: Review

References (254)

1. Al-Asmari AI, Anderson RA and Appelblad P. Direct determination of ethyl glucuronide and ethyl sulfate in postmortem urine specimens using hydrophilic interaction liquid chromatography-electrospray ionization-tandem mass spectrometry. Journal of Analytical Toxicology 2010; 34: 261-272.
2. Ali I, Gaitonde VD and Grahn A. Halo columns: new generation technology for high speed liquid chromatography. Journal of Chromatographic Science 2010; 48: 386-394.
3. Allen KR. Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine. Clinical Toxicology 2006; 44: 147-153.
4. Allen KR, Azad R, Field HP and Blake DK. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Annals of Clinical Biochemistry 2005; 42: 277-284.
5. Alpert AJ. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. Journal of Chromatography A 1990; 499: 177-196.
6. Andersson M, Gustavsson E, Stephanson N and Beck O. Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3, 4-methylenedioxyamphetamine and 3, 4-methylenedioxymethamphetamine in urine drug testing. Journal of Chromatography B 2008; 861: 22-28.
7. Annesley TM. Ion suppression in mass spectrometry. Clinical Chemistry 2003; 49: 1041-1044.
8. Annesley TM. Methanol-associated matrix effects in electrospray ionisation tandem mass spectrometry. Clinical Chemistry 2007; 53: 1827-1834.
9. Apollonio LG, Pianca DJ, Whittall IR, Maher W and Kyd JM. A demonstration of the use of ultra-performance liquid chromatography-mass spectrometry [UPLC/MS] in the determination of amphetamine-type substances and ketamine for forensic and toxicological analysis. Journal of Chromatography B 2006; 836: 111-115.
10. Ariffin MM and Anderson RA. LC/MS/MS analysis of quaternary ammonium drugs and herbicides in whole blood. Journal of Chromatography B 2006; 842: 91-97.
11. Ashman MJ, van der Nagel BC and Mathot RA. Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Biomedical Chromatography 2010; 24: 969-976.
12. Badoud F, Grata E, Perrenoud L, Avois L, Saugy M, Rudaz S and Veuthey J-L. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. I. Screening analysis. Journal of Chromatography A 2009; 1216: 4423-4433.
13. Badoud F, Grata E, Perrenoud L, Saugy M, Rudaz S and Veuthey J-L. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II. Confirmatory analysis. Journal of Chromatography A 2010; 1217: 4109-4119.
14. Beck O, Öhman I and Nordgren HK. Determination of lamotrigine and its metabolites in human plasma by liquid chromatography-mass spectrometry. Therapeutic Drug Monitoring 2006; 28: 603-607.
15. Berg T, Lundanes E, Christophersen AS and Strand DH. Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS/MS. Journal of Chromatography B 2009; 877: 421-432.
16. Berna MJ, Ackermann BL and Murphy AT. High-throughput chromatographic approaches to liquid chromatographic/tandem mass spectrometric bioanalysis to support drug discovery and development. Analytica Chimica Acta 2004; 509: 1-9.
17. Beyer J, Peters FT, Kraemer T and Maurer HH. Detection and validation of toxic alkaloids in human blood plasma-comparison of LC-APCI-MS with LC-ESI-MS/MS. Journal of Mass Spectrometry 2007; 42: 621-633.
18. Blanchard J. Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysis. Journal of Chromatography 1981; 226: 455-460.
19. Blomberg LG. Two new techniques for sample preparation in bioanalysis: microextraction in packed sorbent (MEPS) and use of a bonded monolith as sorbent for sample preparation in polypropylene tips for 96-well plates. Analytical and Bioanalytical Chemistry 2009; 393: 797-807.
20. Bogusz MJ, Al-Enazi E, Hassan H, Abdel-Jawaad J, Al-Ruwaily J and Al-Tufail M. Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pre-treatment procedure. Journal of Chromatography B 2007; 850: 471-480.
21. Bonfiglio R, King RC, Olah TV and Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Communications in Mass Spectrometry 1999; 13: 1175-1185.
22. Bouzas NF, Dresen S, Munz B and Weinmann W. Determination of basic drugs of abuse in human serum by online extraction and LC-MS/MS. Analytical and Bioanalytical Chemistry 2009; 395: 2499-2507.
23. Bristow AWT, Webb KS, Lubben AT and Halket J. Reproducible product-ion tandem mass spectra on various liquid chromatography/mass spectrometry instruments for the development of spectral libraries. Rapid Communications in Mass Spectrometry 2004; 18: 1447-1454.
24. Capiello A, Famiglini G, Palma P and Trufelli H. Matrix effects in liquid chromatography-mass spectrometry. Journal of Liquid Chromatography and Related Technologies 2010; 33: 1067-1081.
25. Ceccato A, Klinkenberg R, Hubert P and Steel B. Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2003; 32: 619-631.
26. Cech NB and Enke CG. Practical implications of some recent studies in electrospray ionization fundamentals. Mass Spectrometry Reviews 2001; 20: 362-387.
27. Chambers, E. A Systematic Approach to Reducing Matrix Effects in LC/MS/MS Analysis. Waters Corporation, 2009.
28. Chambers E, Wagrowski-Diehl DM, Lu Z and Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. Journal of Chromatography B 2007; 852: 22-34.
29. Chassaing C, Stafford H, Luckwell J, Wright A and Edgington A. A parallel micro turbulent flow chromatography-tandem mass spectrometry method for the analysis of a pharmaceutical compound in plasma. Chromatographia 2005; 62: 17-24.
30. Chauve B, Guillarme D, Cleon P and Veuthey J-L. Evaluation of various HILIC materials for the fast separation of polar compounds. Journal of Separation Science 2010; 33: 752-764.
31. Chen Y, Guo Z, Wang X and Qui C. Sample preparation. Journal of Chromatography A 2008; 1184: 191-219.
32. Chimalakonda KC, Hailey C, Black R, Beekman A, Carlisle R, Lowman-Smith E, Singletary H, Owens SM and Hendrickson H. Development and validation of an LC-MS/MS method for determination of phencyclidine in human serum and its application to human drug abuse cases. Analytical Methods 2010; 2: 1249-1254.
33. Chin C, Zhang ZP and Karnes HT. A study of matrix effects on an LC-MS/MS assay for olanzapine and desmethyl olanzapine. Journal of Pharmaceutical and Biomedical Analysis 2004; 36: 1149-1467.
34. Choo RE, Jansson LM, Scheidweiler K and Huestis MA. A validated liquid chromatography-atmospheric pressure ionization-tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1, 5-dimethy-3, 3-diphenylpyrrolidine (EDDP), and 2-ethyl-5-methyl-3, 3-diphenylpyroline (EMDP) in human breast milk. Journal of Analytical Toxicology 2007; 31: 265-269.
35. Concheiro M, de Castro A, Quintela O, López-Rivadulla M and Cruz A. Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography-mass spectrometry. An application to 156 road fatalities. Journal of Chromatography B 2006; 832: 81-89.
36. Concheiro M, De Castro A, Quintela O, Cruz A and Lopez-Rivadulla M. Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion. Journal of Analytical Toxicology 2007; 31: 573-580.
37. Couchman L, Morgan PE and Flanagan RJ. Basic drug analysis by strong cation-exchange liquid chromatography-tandem mass spectrometry: simultaneous analysis of amisulpride, and of metamfetamine and amfetamine in serum/plasma. Biomedical Chromatography, in press, 2010a; doi: 10.1002/bmc.1530.
38. Couchman L, Nooijen P, Birch M, Robinson S and Flanagan R. Simultaneous and sensitive analysis of dasatinib, imatinib, norimatinib and nilotinib in human plasma using TurboFlow LC-MS/MS. Toxichem Krimtech 2010b; 77: 218.
39. Coulter C, Taruc M, Tuyay J and Moore C. Antidepressant drugs in oral fluid using liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology 2010; 34: 64-72.
40. Cruz-Vera M, Lucena R, Cárdenas S and Valcárcel M. Sorptive microextraction for liquid-chromatographic determination of drugs in urine. Trends in Analytical Chemistry 2009; 28: 1164-1173.
41. Dams R, Murphy CM, Lambert WE and Huestis MA. Urine testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2003a; 17: 1665-1670.
42. Dams R, Huestis MA, Lambert WA and Murphy CM. Matrix Effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. Journal of the American Society for Mass Spectrometry 2003b; 14: 1290-1294.
43. Decaestecker TN, Coopman EM, Van Peteghem CH and Van Bocxlaer JF. Suitability testing of commercial solid-phase extraction sorbents for sample clean-up in systematic toxicological analysis using liquid chromatography-(tandem) mass spectrometry. Journal of Chromatography B 2003; 789:19-25.
44. Decaestecker TN, Vande Casteele SR, Wallemacq P, Van Peteghem CH, Defore DL and Van Bocxlaer JF. Information-dependent acquisition-mediated LC-MS/MS screening procedure with semi-quantitative potential. Analytical Chemistry 2004; 76: 6365-6373.
45. Deventer K, Delbeke FT, Roels K and Van Eenoo P. Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry. Biomedical Chromatography 2002; 16: 529-535.
46. Deventer K, Van Eenoo P and Delbeke FT. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry. Biomedical Chromatography 2006; 20: 429-433.
47. Dinis-Oliveira RJ, Carvalho F, Duarte JA, Remaio F, Marques A, Santos A and Magalhaes T. Collection of biological samples in forensic toxicology. Toxicology Mechanisms and Methods 2010; 20: 363-414.
48. Doherty B, Rodriguez V, Leslie JC, McClean S and Franklin Smyth W. An electrospray ionisation tandem mass spectrometric investigation of selected psychoactive pharmaceuticals and its application in drug and metabolite profiling by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2007; 21: 2031-2038.
49. Dresen S, Kempf J and Weinmann W. Electrospray-ionisation MS/MS library of drugs as database for method development and drug identification. Forensic Science International 2006; 161: 86-91.
50. Dresen S, Gergov M, Politi L, Halter C and Weinmann W. ESI-MS/MS library of 1, 253 compounds for application in forensic and clinical toxicology. Analytical and Bioanalytical Chemistry 2009; 395: 2521-2526.
51. Dresen S, Ferreiros N, Gnann H, Zimmerman R and Weinmann W. Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP® LC-MS/MS system and library searching. Analytical and Bioanalytical Chemistry 2010; 396: 2425-2434.
52. Du LH and White RL. Reducing glycerophosphocholine lipid matrix interference effects in biological fluid assays by high-turbulence liquid chromatography. Rapid Communications in Mass Spectrometry 2008; 22: 3362-3370.
53. Edinboro LE, Backer RC and Poklis A. Direct analysis of opiates in urine by liquid chromatography-tandem mass spectrometry Journal of Analytical Toxicology 2005; 29: 704-710.
54. Edwards SR and Smith MT. Simultaneous determination of morphine, oxycodone, morphine-3-glucuronide, and noroxycodone concentrations in rat serum by high performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Journal of Chromatography B 2005; 814: 241-249.
55. Eichhorst JC, Etter ML, Rousseaux N and Lehotay DC. Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clinical Biochemistry 2009; 42: 1531-1542.
56. ElSohly MA, Gul W, ElSohly KM, Avula B and Khan IA. LC-MS-(TOF) analysis method for benzodiazepines in urine samples from alleged drug-facilitated sexual assault victims. Journal of Analytical Toxicology 2006; 30: 524-538.
57. EMEA/CHMP. Guideline on Validation of Bioanalytical Methods (Draft). EMEA/CHMP/EWP/192217/2009. European Medicines Agency/Committee for Medicinal Products for Human Use, 2009.
58. FDA/CDER. Guidance for Industry. Bioanalytical Method Validation. Food and Drug Administration/Center for Drug Evaluation and Research, 2001. Available from: (accessed 28 June 2010).
59. Fekete S, Fekete J and Ganzler K. Shell and small particles; evaluation of new column technology. Journal of Pharmaceutical and Biomedical Analysis 2009; 49: 64-71.
60. Feng J, Wang L, Dai I, Harmon T and Bernert JT. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS. Journal of Analytical Toxicology 2007; 31: 359-368.
61. Fernandez MMR, Laloup M, Wood M, De Boeck G, Lopez-Rivadulla M, Wallemacq P and Samyn N. Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine. Journal of Analytical Toxicology 2007; 31: 497-504.
62. Flanagan RJ, Harvey EJ and Spencer EP. HPLC of basic drugs on microparticulate strong cation-exchange materials-a review. Forensic Science International 2001; 121: 97-102.
63. Flanagan RJ, Connally G and Evans JM. Analytical toxicology: guidelines for sample collection postmortem. Toxicology Reviews 2005; 24: 63-71.
64. Flanagan RJ, Morgan PE, Spencer EP and Whelpton R. Micro-extraction techniques in analytical toxicology: short review. Biomedical Chromatography 2006; 20: 530-538.
65. Flanagan RJ, Taylor A, Watson ID and Whelpton R. Fundamentals of Analytical Toxicology. John Wiley and Sons, New York, 2007.
66. Fountain KJ, Xu J, Diehl DM and Morrison D. Influence of stationary phase chemistry and mobile-phase composition on retention, selectivity, and MS response in hydrophilic interaction chromatography. Journal of Separation Science 2010; 33: 740-751.
67. Fox EJ, Twigger S and Allen KR. Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: problems in routine practice. Annals of Clinical Biochemistry 2009; 46: 50-57.
68. Fu I, Woolf EJ and Matuszewski BK. Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection. Journal of Pharmaceutical and Biomedical Analysis 1998; 18: 347-357.
69. Gallagher RT, Balogh MP, Davey P, Jackson MR, Sinclair I and Southern LJ. Combined electrospray ionization-atmospheric pressure chemical ionization source for use in high-throughput LC-MS applications. Analytical Chemistry 2003; 75: 973-977.
70. Gergov M, Boucher B, Ojanperä I and Vuori E. Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. Rapid Communications in Mass Spectrometry 2001; 15: 521-526.
71. Gergov M, Ojanperä I, and Vuori E. Simultaneous screening for 238 drugs in blood by liquid-chromatography-ionspray tandem mass spectrometry with multiple-reaction monitoring. Journal of Chromatography B 2003; 795: 41-53.
72. Gergov M, Weinmann W, Meriluoto J, Uusitalo J and Ojanperä I. Comparison of product ion spectra obtained by liquid chromatography/triple-quadrupole mass spectrometry for library search. Rapid Communications in Mass Spectrometry 2004; 18: 1039-1046.
73. Glover SJ and Allen KR. Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay. Annals of Clinical Biochemistry 2010; 47: 111-117.
74. Goebel C, Trout GJ and Kazlauskas R. Rapid screening method for diuretics in doping control using automated solid phase extraction and liquid chromatography-electrospray tandem mass spectrometry. Analytica Chimica Acta 2004; 502: 65-74.
75. Gosetti F, Mazzucco E, Zampieri D and Gennaro MC. Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. Journal of Chromatography A 2010; 1217: 3929-3937.
76. Grumbach ES, Diehl DM and Neue UD. The application of novel 1.7 μm ethylene briged hybrid particles for hydrophilic interaction chromatography. Journal of Separation Science 2008; 31: 1511-1518.
77. Guillarme D, Ruta J, Rudaz S and Veuthey J-L. New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches. Analytical and Bioanalytical Chemistry 2010a; 397: 1069-1082.
78. Guillarme D, Bonvin G, Badoud F, Schappler J, Rudaz S and Veuthey J-L. Fast chiral separation of drugs using columns packed with sub-2 μm particles and ultra-high pressure. Chirality 2010b; 22: 320-330.
79. Guo B, Li C, Deng Z, Chen S, Ji Z, Zhang J, Chen M and Xu F. A new method for measurement of (-)-sophocarpine, a candidate therapeutic for viral myocarditis, in plasma: application to a toxicokinetic study in beagle dogs Rapid Communications in Mass Spectrometry 2005; 19: 2840-2848.
80. Gustavsson E, Andersson M, Stephanson N and Beck O. Validation of direct injection electrospray LC-MS/MS for confirmation of opiates in urine drug testing. Journal of Mass Spectrometry 2007; 42: 881-889.
81. Hemstrom P and Irgum K. Hydrophilic interaction liquid chromatography. Journal of Separation Science 2006; 29: 1784-1821.
82. Hendriks G, Uges DRA and Franke JP. Reconsideration of sample pH adjustment in bioanalytical liquid-liquid extraction of ionisable compounds. Journal of Chromatography B 2007; 853: 234-241.
83. Herrin GL, Horton McCurdy H and Wall WH. Investigation of an LC-MS-MS (QTrap®) method for the rapid screening and identification of drugs in postmortem toxicology whole blood samples. Journal of Analytical Toxicology 2005; 29: 599-606.
84. de Hoffman E and Stroobant V. Mass Spectrometry: Principles and Applications. Wiley-Blackwell, Chichester, 2007.
85. Holler JM, Vorce SP, Bosy TZ and Jacobs A. Quantitative and isomeric determination of amphetamine and methamphetamine from urine using a nonprotic elution solvent and R(-)-alpha-methoxy-alpha-trifluoromethylphenylacetic acid chloride derivatization. Journal of Analytical Toxicology 2005; 29: 652-657.
86. Holt DW, Lee T, Jones K and Johnston A. Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection. Clinical Chemistry 2000; 46: 1179-1183.
87. Hopley C, Bristow T, Lubben A, Simpson A, Bul E, Klagkou K, Herniman J and Langley J. Towards a universal product ion mass spectral library-reproducibility of product ion spectra across eleven different mass spectrometers. Rapid Communications in Mass Spectrometry 2008; 22: 1779-1786.
88. Hough JM, Haney CA, Voyksner RD and Bereman R. Evaluation of electrospray transport CID for the generation of searchable libraries. Analytical Chemistry 2000; 72: 2265-2270.
89. Ismaeil OA, Halquist MS, Elmalmy MY, Shalaby A and Karnes HT. Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations. Journal of Chromatography B 2008; 875: 333-343.
90. ISO/IEC 17025. ISO/IEC 17025:2005. Incorporating Corrigendum no. 1. Published under the authority of the Standards Policy and Strategy Committee on 29 June 2005, ISBN 0 580 46330 3.
91. Jagerdeo E, Montgomery MA, Sibum M, Sasaki TA and LeBeau MA. Rapid analysis of cocaine and metabolites in urine using a completely automated solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry method. Journal of Analytical Toxicology 2008; 32: 570-576.
92. Janda I, Weinmann W, Kuehnle T, Lahode M and Alt A. Determination of ethyl glucuronide in human hair by SPE and LC-MS/MS. Forensic Science International 2002; 128: 59-65.
93. Jansen R, Lachâtre G and Marquet P. LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings. Clinical Biochemistry 2005; 38: 362-372.
94. Jemal M, Ouyang Z and Xia Y-Q. Systematic LC-MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomedical Chromatography 2010; 24: 2-19.
95. Jenkins KM, Young MS, Mallet CR and Elian AA. Mixed-mode solid-phase extraction procedures for the determination of MDMA and metabolites in urine using LC-MS, LC-UV, or GC-NPD. Journal of Analytical Toxicology 2004; 28: 50-58.
96. Jian WY, Edom RW, Xu YD and Weng ND. Recent advances in application of hydrophilic interaction liquid chromatography for quantitative bioanalysis. Journal of Separation Science 2010; 33: 681-697.
97. Johnson K and Kozak M. Implementation of ultra-high resolution mass spectrometer Exactive™ for analysis of EtG and EtS in human urine. Toxichem Krimtech 2010; 77: 262.
98. Jourdil N, Bessard J, Vincent F, Eysseric H and Bessard G. Automated solid-phase extraction and liquid chromatography-electrospray ionization-mass spectrometry for the determination of flunitrazepam and its metabolites in human urine and plasma samples. Journal of Chromatography B 2003; 788: 207-219.
99. Kala SV, Harris SE, Freijo TD and Gerlich S. Validation of analysis of amphetamines, opiates, phencyclidine, cocaine, and benzoylecgonine in oral fluids by liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology 2008; 32: 605-611.
100. Kanno S, Watanabe K, Hirano S, Yamagishi I, Gonmori K, Minakata K and Suzuki O. Application of thermoresponsive HPLC to forensic toxicology: determination of barbiturates in human urine. Forensic Toxicology 2009; 27: 103-106.
101. Kasprzyrk-Horden B, Kondakal VVR and Baker DR. Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry. Journal of Chromatography A 2010; 1217: 4575-4586.
102. Kataoka H. Recent developments and applications of microextraction techniques in drug analysis. Analytical and Bioanalytical Chemistry 2010; 396: 339-364.
103. Kaushik R, Levine B and LaCourse WR. A brief review: HPLC methods to directly detect drug glucuronides in biological matrices (Part 1). Analytica Chimica Acta 2006; 556: 255-266.
104. Keller BO, Sui J, Young AB and Whittal RM. Interferences and contaminants encountered in modern mass spectrometry. Anal Chim Acta 2008; 627: 71-81.
105. Kim JY, Cheong JC, Ko BJ, Lee SK, Yoo HH, Jin C and In MK. Simultaneous determination of methamphetamine, 3, 4-methylenedioxy-N-methylamphetamine, 3, 4-methylenedioxy-N-ethylamphetamine, N, N-dimethylamphetamine, and their metabolites in urine by liquid chromatography-electrospray ionization-tandem mass spectrometry Archives of Pharmacal Research 2008; 31: 1644-1651.
106. Kirchherr H and Kühn-Velten WN. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. Journal of Chromatography B 2006; 843: 100-113.
107. Kirkland JJ, Langlois TJ and DeStefano JJ. Fused core particles for HPLC columns. American Laboratory 2007; 39: 18-21.
108. Kloepfer A, Quintana JB, and Reemtsma T. Operational options to reduce matrix effects in liquid chromatography-electrospray ionisation-mass spectrometry analysis of aqueous environmental samples. Journal of Chromatography A 2005; 1067: 153-160.
109. Kostiainen R and Kauppila TJ. Effect of eluent on the ionisation process in liquid-chromatography-mass spectrometry. Journal of Chromatography A 2009; 1216: 685-699.
110. Kristoffersen L, Øiestad EL, Opdal MS, Krogh M, Lundanes E, and Christophersen AS. Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhytmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry. Method development and robustness testing by experimental design. Journal of Chromatography B 2007; 850: 147-160.
111. Kruve A, Leito I, and Herodes K. Combating matrix effects in LC/ESI/MS: the extrapolative dilution approach. Analytica Chimica Acta 2009; 651: 75-80.
112. Kushnir MM, Rockwood AL, Nelson GJ, Yue B and Urry FM. Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clinical Biochemistry 2005; 38: 319-327.
113. Laloup M, del Mar Ramirez Fernandez M, De Boeck G, Wood M, Maes V and Samyn N. Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine, and hair. Journal of Analytical Toxicology 2005; 29: 616-626.
114. Langman LJ, Bjergum MW, Williamson CL and Crow FW. Sensitive method for detection of cocaine and associated analytes by liquid chromatography-tandem mass spectrometry in urine. Journal of Analytical Toxicology 2009; 33: 447-455.
115. LeBeau MA, Montgomery MA, Wagner JR and Miller ML. Analysis of biofluids for flunitrazepam and metabolites by electrospray liquid chromatography/mass spectrometry. Journal of Forensic Sciences 2000; 45: 1133-1141.
116. Lee HK, Ho CS, Iu YP, Lai PSJ, Shek CC, Lo Y-C, Klinke HB and Wood M. Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry. Analytica Chimica Acta 2009; 649: 80-90.
117. Lee XP, Kumazawa T, Sato J, Shoji Y, Hasegawa C, Karibe C, Arinobu T, Seno H and Sato K. Simple method for the determination of benzodiazepines in human body fluids by high-performance liquid chromatography-mass spectrometry. Analytica Chimica Acta 2003; 492: 223-231.
118. Lee XP, Kumazawa T, Fujishiro M, Hasegawa C, Marumo A, Shoji Y, Arinobu T, Seno H and Sato K. Simple method for determination of triazolam in human plasma by high-performance liquid chromatography/tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2006; 41: 64-69.
119. Leverence R, Avery MJ, Kavetskaia O, Bi H, Hop CECA and Gusev AI. Signal suppression/enhancement in HPLC-ESI-MS/MS from concomitant medications. Biomedical Chromatography 2007; 21: 1143-1150.
120. Li XF, Ma MS, Scherban K and Tam YK. Liquid chromatography-electrospray mass spectrometric studies of ginkgolides and bilobalide using simultaneous monitoring of proton, ammonium and sodium adducts. Analyst 2002; 127: 641-646.
121. Liang HR, Foltz RL, Meng M and Bennett P. Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labeled internal standards in quantitative liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2003; 17: 2815-2821.
122. Lindegardh N, Annerberg A, White NJ and Day NPJ. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma. Stable isotope labeled internal standard does not always compensate for matrix effects. Journal of Chromatography B 2008; 862: 227-236.
123. Liotta E, Gottardo R, Bertaso A and Polettini A. Screening for pharmaco-toxicologically relevant compounds in biosamples using high-resolution mass spectrometry: a 'metabolomic' approach to the discrimination between isomers. Journal of Mass Spectrometry 2010; 45: 261-271.
124. Lips AGAM, Lameijer W, Fokkens RH and Nibbering NMM. Methodology for the development of a drug library based upon collision-induced fragmentation for the identification of toxicologically relevant drugs in plasma samples. Journal of Chromatography B 2001; 759: 191-207.
125. Little JL, Wempe MF and Buchanan CM. Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: examining lipid matrix ionisation effects in plasma. Journal of Chromatography B 2006; 833: 219-230.
126. Liu F, Xu Y, Huang JC, Gao S and Guo XQ. Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma. Biomedical Chromatography 2007; 21: 1272-1278.
127. Liu HC, Liu RH, Ho HO and Lin DL. Development of an information-rich LC-MS/MS database for the analysis of drugs in post-mortem specimens. Analytical Chemistry 2009; 81: 9002-9011.
128. Liu HC, Liu RH, Lin DL and Ho HO. Rapid screening and confirmation of drugs and toxic compounds in biological specimens using liquid chromatography/ion trap tandem mass spectrometry and automated library searching. Rapid Communications in Mass Spectrometry 2010; 24: 75-84.
129. Luiz Costa J and Lanaro R. Use of hydrophilic interaction liquid chromatography-tandem mass spectrometry for the fast determination of gamma-hydroxybutyrate (GHB) in plasma and urine. Toxichem Krimtech 2010; 77: 201.
130. Lynch KL, Breaud AR, Vandenberghe H, Wu AHB and Clarke W. Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clinica Chimica Acta 2010; 411: 1474-1481.
131. Mallet CR, Lu Z, Fisk R, Mazzeo JR and Neue UD. Performance of an ultra-low elution-volume 96-well plate: drug discovery and development applications. Rapid Communications in Mass Spectrometry 2003; 17: 163-170.
132. Maralikova B and Weinmann W. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. Journal of Chromatography B 2004; 811: 21-30.
133. Marchi I, Viette V, Badoud F, Fathi M, Saugy M, Rudaz S and Veuthey J-L. Characterization and classification of matrix effects in biological samples analyses. Journal of Chromatography A 2010; 1217: 4071-4078.
134. Marin SJ, Coles R, Merrell M and McMillin GA. Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS. Journal of Analytical Toxicology 2008; 32: 491-498.
135. Marquet P. Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology? Therapeutic Drug Monitoring 2002; 24: 125-133.
136. Marquet P and Lachâtre G. Liquid chromatography-mass spectrometry: potential in forensic and clinical toxicology. Journal of Chromatography B 1999; 733: 93-118.
137. Marquet P, Venisse N, Lacassie E and Lachâtre G. In-source CID mass spectral libraries for the 'general unknown' screening of drugs and toxicants. Analusis 2000; 28: 925-934.
138. Marquet P, Saint-Marcoux F, Gamble TN and LeBlanc JCY. Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear-ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique. Journal of Chromatography B 2003; 789: 9-18.
139. Matuszewski BK. Standard line slopes as a measure of relative matrix effect in quantitative HPLC-MS bioanalysis. Journal of Chromatography B 2006; 830: 293-300.
140. Matuszewski BK, Constanzer ML and Chavez-Eng CM. Matrix effect in quantitative LC-MS/MS analyses of biological fluids: a method for the determination of finasteride in human plasma at pictogram per millilitre concentrations. Analytical Chemistry 1998; 70: 882-889.
141. Matuszewski BK, Constanzer ML, and Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry 2003; 75: 3019-3030.
142. Maurer HH. Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid. Analytical and Bioanalytical Chemistry 2005; 381: 110-118.
143. Maurer HH. Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control. Journal of Mass Spectrometry 2006; 41: 1399-1413.
144. Maurer HH. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Analytical and Bioanalytical Chemistry 2007; 388: 1315-1325.
145. Maurer HH. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification and quantification of drugs in clinical and forensic toxicology. Therapeutic Drug Monitoring 2010; 32: 324-327.
146. Maurer HH and Peters FT. Towards high-throughput drug screening using mass spectrometry. Therapeutic Drug Monitoring 2005; 27: 686-688.
147. Mazzarino M, de la Torre X, Di Santo R, Fiacco I, Rosi F and Botrè F. Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2010; 24: 749-760.
148. McCalley DV. The challenges of the analysis of basic compounds by high performance liquid chromatography: some possible approaches for improved separations. Journal of Chromatography A 2010; 1217: 858-880.
149. Medvedovici A, Albu F and David V. Handling drawbacks of mass spectrometric detection coupled to liquid chromatography in bioanalysis. Journal of Liquid Chromatography and Related Techniques 2010; 33: 1255-1286.
150. Mei H, Hsieh YS, Nardo C, Xu XY, Wang SY, Ng K and Korfmacher WA. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Communications in Mass Spectrometry 2003; 17: 97-103.
151. Mercerolle M, Denooz R, Lachâtre G and Charlier C. A fatal case of bupropion (Zyban®) overdose. Journal of Analytical Toxicology 2008; 32: 192-196.
152. Ming DS and Heathcote J. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology 2009; 33: 198-203.
153. Moody DE, Slawson MH, Strain EC, Laycock JD, Spanbauer AC and Foltz RL. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a conformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies. Analytical Biochemistry 2002; 306: 31-39.
154. Morgan PE, Tapper J and Spencer EP. Measurement of total mirtazapine and normitrazapine in plasma/serum by liquid chromatography with fluorescence detection. Journal of Chromatography B 2003; 798: 211-215.
155. Morgan P, Couchman L, Robinson S, McDonnell S and Flanagan R. Analysis of clozapine and norclozapine in plasma using on-line sample preparation and LC-MS/MS. The Column 2010; 6(14): 10-16.
156. Mortier KA, Maudens KE, Lambert WE, Clauwaert KM, Van Bocxlaer JF, Deforce DL, Van Peteghem CH and De Leenheer AP. Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry. Journal of Chromatography B 2002; 779: 321-330.
157. Mortier KA, Zhang G-F, Van Peteghem CH and Lambert WE. Adduct formation in quantitative bioanalysis: effect of ionization conditions on paclitaxel. Journal of the American Society for Mass Spectrometry 2004; 15: 585-592.
158. Mueller CA, Weinmann W, Dresen S, Schreiber A and Gergov M. Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Communications in Mass Spectrometry 2005; 19: 1332-1338.
159. 2]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometry. Journal of Chromatography B 2007; 857: 1-8.
160. Nakamura M, Ohmori T, Itoh Y, Terashita M and Hirano K. Simultaneous determination of benzodiazepines and their metabolites in human serum by liquid chromatography-tandem mass spectrometry using a high-resolution octadecyl silica column compatible with aqueous compounds. Biomedical Chromatography 2009; 23: 357-364.
161. Napoli, KL. More on methanol-associated matrix effects in electrospray ionisation tandem mass spectrometry. Clinical Chemistry 2009; 55: 1250-1252.
162. Nguyen DTT, Guillarme D, Rudaz S and Veuthey J-L. Fast analysis in liquid chromatography using small particle size and high pressure. Journal of Separation Science 2006; 29: 1836-1848.
163. Nguyen DTT, Guillarme D, Heinisch S, Barrioulet M-P, Rocca J-L, Rudaz S and Veuthey J-L. High throughput liquid chromatography with sub-2 μm particles and high temperature. Journal of Chromatography A 2007; 1167: 76-84.
164. Nguyen HP and Schug KA. The advantages of ESI-MS detection in conjunction with HILIC mode separations: fundamentals and applications. Journal of Separation Science 2008; 31: 1465-1480.
165. Niessen WMA. Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-throughput screening. Journal of Chromatography A 2003, 1000: 413-436.
166. Nordgren HK and Beck O. Multicomponent screening for drugs of abuse: direct analysis of urine by LC-MS-MS. Therapeutic Drug Monitoring 2004; 26: 90-97.
167. Nordgren HK, Holmgren P, Liljeberg P, Eriksson N and Beck O. Application of direct urine LC-MS/MS analysis for screening of novel substances in drug abusers. Journal of Analytical Toxicology 2005; 29: 234-239.
168. Nováková L and VlČová H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Analytica Chimica Acta 2009; 656: 8-35.
169. Nozaki K, Tarui A, Osaka I, Kawasaki H and Arakawa R. Elimination technique for alkali metal ion adducts from an electrospray ionisation process using an on-line ion suppressor. Analytical Sciences 2010; 26: 715-718.
170. Oberacher H, Pavlic M, Libiseller K, Schubert B, Sulyok M, Schuhmacher R, Csaszer E and Kofeler HC. On the inter-instrument and the inter-laboratory transferability of a tandem mass spectral reference library: 2. Optimisation and characterization of the search algorithm. Journal of Mass Spectrometry 2009; 44: 494-502.
171. O'Halloran S and Ilett KF. Evaluation of a deuterium-labeled internal standard for the measurement of sirolimus by high-throughput HPLC electrospray ionisation tandem mass spectrometry. Clinical Chemistry 2008; 54: 1386-1389.
172. Ojanperä I, Pelander A, Laks S, Gergov M, Vuori E and Witt M. Application of accurate mass measurement to urine drug screening. Journal of Analytical Toxicology 2005; 29: 34-40.
173. Ojanperä S, Pelander A, Pelzing M, Krebs I, Vuori E and Ojanperä I. Isotopic pattern and accurate mass determination in urine drug screening by liquid-chromatography/time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry 2006; 20:1161-1167.
174. Parkin MC, Turfus SC, Smith NW, Halket JM, Braithwaite RA, Elliott SP, Osselton MD, Cowan DA and Kicman AT. Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 2008; 876: 137-142.
175. Pavlic M, Libiseller K and Oberacher H. Combined use of ESI-QqTOF-MS and ESI-QqTOF-MS/MS with mass-spectral library search for qualitative analysis of drugs. Analytical and Bioanalytical Chemistry 2006; 386: 69-82.
176. Pedersen-Bjergaard S and Rasmussen KE. Electrical potential can drive liquid-liquid extraction for sample preparation in chromatography. Trends in Analytical Chemistry 2008; 27: 934-941.
177. Peiris DM, Lam W, Michael S, and Ramanathan R. Distinguishing N-oxide and hydroxyl compounds: impact of heated capillary/heated ion transfer tube in inducing atmospheric pressure ionisation source decomposition. Journal of Mass Spectrometry 2004; 39: 600-606.
178. Pelander A, Ojanperä I, Laks S, Rasanen I and Vuori E. Toxicological screening with formula-based metabolite identification by liquid-chromatography/time-of-flight mass spectrometry. Analytical Chemistry 2003; 75: 5710-5718.
179. Pelander A, Ristimaa J, Rasanen I, Vuori E and Ojanperä I. Screening for basic drugs in hair of drug addicts by liquid chromatography/time-of-flight mass spectrometry. Therapeutic Drug Monitoring 2008; 30: 717-724.
180. Pelander A, Ristimaa J and Ojanperä I. Vitreous humor as an alternative matrix for comprehensive drug screening in postmortem toxicology by liquid chromatography-time-of-flight mass spectrometry. Journal of Analytical Toxicology 2010; 34: 312-318.
181. Peters FT and Maurer HH. Bioanalytical method validation and its implications for forensic and clinical toxicology-a review. Accreditation and Quality Assurance 2002; 7: 441-449.
182. Peters FT, Drummer OH and Musshoff F. Validation of new methods. Forensic Science International 2007; 165: 216-224.
183. Peters RJB, Oosterink JE, Stolker AAM, Georgakopoulos C and Nielen MWF. Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. Analytical and Bioanalytical Chemistry 2010; 396: 2583-2598.
184. Pihlainen K, Sippola E and Kostiainen R. Rapid identification and quatification of compounds with forensic interest using fast liquid chromatography-ion trap mass spectrometry and library searching. Journal of Chromatography A 2003; 994: 93-102.
185. Polettini A. Applications of LC-MS in Toxicology. Pharmaceutical Press: London, 2006.
186. Polettini A, Gottardo R, Pascali JP and Tagliaro F. Implementation and performance evaluation of a database of pharmaco/toxicologically relevant compounds in biological samples using electrospray ionisation-time-of-flight mass spectrometry. Analytical Chemistry 2008; 80: 3050-3057.
187. Politi L, Morini L and Polettini A. A direct screening procedure for diuretics in human urine by liquid chromatography-tandem mass spectrometry with information dependent acquisition. Clinica Chimica Acta 2007; 386: 46-52.
188. Pucci V, Di Palma S, Alfieri A, Bonelli F and Monteagudo E. A novel strategy for reducing phospholipids-based matrix effects in LC-ESI-MS bioanalysis by means of HybridSPE. Journal of Pharmacautical and Biomedical Analysis 2009; 50: 867-871.
189. Quintela O, Lendoiro E, Cruz A, de Castro A, Quevedo A, Jurado C and López-Rivadulla M. Hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC-MS/MS) determination of cocaine and its metabolites benzoylecgonine, ecgonine methyl ester, and cocaethylene in hair samples. Analytical and Bioanalytical Chemistry 2010; 396: 1703-1712.
190. Remane D, Wissenbach DK, Meyer MR and Maurer HH. Systematic investigation of ion suppression and enhancement effects of fourteen stable-isotope-labeled internal standards by their native analogues by atmospheric-pressure chemical ionisation and electrospray ionisation and their relevance for multi-analyte liquid chromatographic/mass soectrometric procedures. Rapid Communications in Mass Spectrometry 2010; 24: 859-867.
191. Rentsch KM. Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry. Journal of Chromatography B 2003; 788: 339-350.
192. Rivier L. Criteria for the identification of compounds by liquid chromatography-mass spectrometry and liquid chromatography-multiple mass spectrometry in forensic toxicology and doping analysis. Analytica Chimica Acta 2003; 492: 69-82.
193. Robandt PP, Reda LJ and Klette KL. Complete automation of solid-phase extraction with subsequent liquid chromatography-tandem mass spectrometry for the quantification of benzoylecgonine, m-hydroxybenzoylecgonine, p- hydroxybenzoylecgonine, and norbenzoylecgonine in urine-application to a high-throughput urine analysis laboratory. Journal of Analytical Toxicology 2008; 32: 577-585.
194. 9-tetrahydrocannabinol-9-carboxylic acid in human urine specimens: application to a high-throughput urine analysis laboratory. Journal of Analytical Toxicology 2009; 33: 456-460.
195. Robb DB, Covey TR and Bruins AP. Atmospheric pressure photoionization: an ionisation method for liquid chromatography-mass spectrometry. Analytical Chemistry 2000; 72: 3653-3659.
196. Roman M, Kronstrand R, Lindstedt D and Josefsson M. Quantitation of seven low-dosage antipsychotic drugs in human postmortem blood using LC-MS-MS. Journal of Analytical Toxicology 2008; 32: 147-155.
197. Rust KY, Baumgartner MR, Meggiolaro N and Kraemer T. Detection and validated quantification of 21 benzopdiazepines/metabolites and 3 'Z-Drugs' in human hair by LC-MS/MS. Toxichem Krimtech 2010; 77: 171.
198. Saar E, Gerostamoulos D, Drummer OH and Beyer J. Comparison of extraction efficiencies and LC-MS-MS matrix effects using LLE and SPE methods for 19 antipsychotics in human blood. Analytical and Bioanalytical Chemistry 2009; 393: 727-734.
199. Saint-Marcoux F, Lachâtre G and Marquet P. Evaluation of an improved general unknown screening procedure using liquid-chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography-diode array detection. Journal of the American Society of Mass Spectrometry 2003; 14: 14-22.
200. Samyn N, Laloup M and De Boeck G. Bioanalytical procedures for determination of drugs of abuse in oral fluid. Analytical and Bioanalytical Chemistry 2007; 388: 1437-1453.
201. Sangster T, Spence M, Sinclair PM, Payne R and Smith C. Unexpected observation of ion suppression in a liquid chromatography/atmospheric pressure chemical ionisation mass spectrometric bioanalytical method. Rapid Communications in Mass Spectrometry 2004; 18: 1361-1364.
202. Sarafraz-Yazdi A and Amiri A. Liquid-phase microextraction. Trends in Analytical Chemistry 2010; 29: 1-14.
203. Sauvage F-L, Saint-Marcoux F, Duretz B, Deporte D, Lachâtre G and Marquet P. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clinical Chemistry 2006; 52: 1735-1742.
204. Sauvage F-L, Gaulier J-M, Lachâtre G and Marquet P. Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clinical Chemistry 2008; 54: 1519-1527.
205. Schellen A, Ooms B, van de Lagemaat D, Vreeken R and van Dongen WD. Generic solid phase extraction-liquid chromatography-tandem mass spectrometry method for fast determination of drugs in biological fluids. Journal of Chromatography B 2003; 788: 251-259.
206. Schuhmacher J, Zimmer D, Tesche F and Pickard V. Matrix effects during analysis of plasma samples by electrospray and atmospheric pressure chemical ionization mass spectrometry: practical approaches to their elimination. Rapid Communications in Mass Spectrometry 2003; 17: 1950-1957.
207. Sergi M, Bafile E, Compagnone D, Curini R, D'Ascenzo G and Romolo FS. Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS. Analytical and Bioanalytical Chemistry 2009; 393: 709-718.
208. Sergi M, Compagnone D, Curini R, D'Ascenzo G, Del Carlo M, Napoletano S and Risoluti R. Micro-solid phase extraction coupled with high-performance liquid chromatography-tandem mass spectrometry for the determination of stimulants, hallucinogens, ketamine and phencyclidine in oral fluids. Analytical Chimica Acta 2010; 675: 132-137.
209. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT and Yacobi A. Bioanalytical method validation-a revisit with a decade of progress. Pharmaceutical Research 2000; 17: 1551-1557.
210. Shen JX, Tama CI and Hayes RN. Evaluation of automated micro solid phase extraction tips (μ-SPE) for the validation of a LC-MS/MS bioanalytical method. Journal of Chromatography B 2006; 843: 275-282.
211. Smith ML, Vorce SP, Holler JM, Shimomura E, Magluilo J, Jacobs AJ and Huestis MA. Modern instrumental methods in forensic toxicology. Journal of Analytical Toxicology 2007; 31: 237-253.
212. Smith RM. Before the injection-modern methods of sample preparation for separation techniques. Journal of Chromatography A 2003; 1000: 3-27.
213. SOFT/AAFS. Forensic Toxicology Laboratory Guidelines. Society of Forensic Toxicology/American Academy of Forensic Sciences, 2006. Available from: (accessed 15 August 2010).
214. Sojo, LE, Lum G and Chee P. Internal standard signal suppression by co-eluting analyte in isotope dilution LC-ESI-MS. Analyst 2003; 128: 51-55.
215. Souverain S, Rudaz S and Veuthey J-L. Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. Journal of Chromatography A 2004; 1058: 61-66.
216. Srinivas NR. Dodging matrix effects in liquid chromatography tandem mass spectrometric assays-compilation of key learnings and perspectives. Biomedical Chromatography 2009; 23: 451-454.
217. Stephanson N, Dahl H, Helander A and Beck O. Direct quantification of ethyl glucuronide in clinical urine samples by liquid chromatography-mass spectrometry. Therapeutic Drug Monitoring 2002; 24: 645-651.
218. Stovkis E, Rosing H and Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Communications in Mass Spectrometry 2005; 19: 401-407.
219. Subramanian M, Birnbaum AK and Remmel RP. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Therapeutic Drug Monitoring 2008; 30: 347-356.
220. Svensson JO, Andersson M, Gustavsson E and Beck O. Electrospray LC-MS method with solid-phase extraction for accurate determination of morphine-, codeine-, and ethylmorphine-glucuronides and 6-acetylmorphine in urine. Journal of Analytical Toxicology 2007; 31: 81-86.
221. Tan A, Hussain S, Musuku A and Massé R. Internal standard response variation during incurred sample analysis by LC-MS/MS: case by case trouble-shooting. Journal of Chromatography B 2009; 877: 3201-3209.
222. Tarcomnicu I, van Nuijs ALN, Aerts K, de Doncker M, Covaci A and Neels H. Ethyl glucuronide determination in meconium and hair by hydrophilic interaction liquid chromatography-mass spectrometry. Forensic Science International 2010; 196: 121-127.
223. Taverniers I, De Loose M and Van Bockstaele E. Trends in quality in the analytical laboratory II. Analytical method validation and quality assurance. Trends in Analytical Chemistry 2004; 23: 535-552.
224. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clinical Biochemistry 2005; 38: 328-334.
225. Thieme D, Sachs H and Thevis M. Formation of the N-methylpyridinium derivative to improve the detection of buprenorphine by liquid chromatography-mass spectrometry. Journal of Mass Spectrometry 2008; 43: 974-979.
226. Thomas A, Kohler M, Schänzer W and Thevis M. Screening for urinary insulin and other bioactive peptides by nanoUPLC-MS/MS for doping control purposes. Toxichem Krimtech 2010a; 77: 183.
227. Thomas A, Guddat S, Kohler M, Krug O, Schanzer W, Petrou M and Thevis M. Comprehensive plasma-screening for known and unknown substances in doping controls. Rapid Communications in Mass Spectrometry 2010b; 24: 1124-1132.
228. Thompson M, Ellison SLR and Wood R. Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC technical report). Pure and Applied Chemistry 2002; 74: 835-855.
229. Thörngren J-O, Östervall F and Garle M. A high-throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS/MS. Journal of Mass Spectrometry 2008; 43: 980-992.
230. Trullols E, Ruisanchez I and Rius FX. Validation of qualitative analytical methods. Trends in Analytical Chemistry 2004, 23: 137-145.
231. Tyrkko E, Pelander A and Ojanperä I. Differentiation of structural isomers in a target drug database by LC/Q-TOFMS using fragmentation prediction. Drug Testing and Analysis 2010; 2: 259-270.
232. Umezawa H, Lee X-P, Arima Y, Hasegawa C, Izawa H, Kumazawa T and Sato K. Simultaneous determination of β-blockers in human plasma using liquid chromatography-tandem mass spectrometry. Biomedical Chromatography 2008; 22: 702-711.
233. Vander Heyden Y, Nijhuis A, Smeyers-Verbeke J, Vandeginste BGM and Massart DL. Guidance for robustness/ruggedness tests in method validation. Journal of Pharmaceutical and Biomedical Analysis 2001; 24: 723-753.
234. van Eeckhaut A, Lanckmans K, Sarre S, Smolders I and Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. Journal of Chromatography B 2009; 877: 2198-2207.
235. Venisse N, Marquet P, Duchoslav E, Dupuy JL and Lachâtre G. A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry. Journal of Analytical Toxicology 2003; 27: 7-14.
236. Verplaetse R and Tytgat J. Development and validation of a sensitive ultra performance liquid chromatography tandem mass spectrometry method for the analysis of fentanyl and its major metabolite norfentanyl in urine and whole blood in forensic context. Journal of Chromatography B 2010; 878: 1987-1996.
237. Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG and Weiner R. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharmaceutical Research 2007; 24: 1962-1973.
238. Vogeser M and Seger C. A decade of HPLC-MS/MS in the routine clinical laboratory-goals for further developments. Clinical Biochemistry 2008; 41: 649-662.
239. Vogeser M and Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clinical Chemistry 2010; 56: 1234-1244.
240. Vuckovic D, Zhang X, Cudjoe E and Pawliszyn J. Solid-phase microextraction in bioanalysis: new devices and directions. Journal of Chromatography A 2010; 1217: 4041-4060.
241. Wang S, Cyronak M and Yang E. Does a stable isotopically labelled internal standard always correct analyte response? A matrix effect study on a LC-MS/MS method for the determination of carvedilol enantiomers in human plasma. Journal of Pharmaceutical and Biomedical Analysis 2007; 43: 701-707.
242. Watson JT and Sparkman OD. Introduction to Mass Spectrometry: Instrumentation, Applications and Strategies for Data Interpretation, 4th edn. Wiley-Blackwell, Chichester, 2007.
243. Weider ME, Brown PR, Grainger L and Teale P. Identification of etamiphylline and metabolites in equine plasma and urine by accurate mass and liquid chromatography/tandem mass spectrometry. Drug Testing and Analysis 2010; 2; 271-277.
244. Wille SMR and Lambert WEE. Recent developments in extraction procedures relevant to analytical toxicology. Analytical and Bioanalytical Chemistry 2007; 388: 1381-1391.
245. Wood R. How to validate analytical methods. Trends in Analytical Chemistry 1999; 18: 624-632.
246. Wu X, Huang W, Lu L, Lin L and Yang X. Simultaneous determination of six alkaloids in blood and urine using a hydrophilic interaction liquid chromatography method coupled with electrospray ionization tandem mass spectrometry. Analytical and Bioanalytical Chemistry 2010; 398: 1319-1327.
247. Xu RN, Fan L, Rieser MJ and El-Shourbagy TA. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2007; 44: 342-355.
248. Yadav M, Patel D, Singhal P, Prasad R, Goswami S, Shrivastav PS and Pande UC. Effect of collision-activated dissociation gas and collision energy on the fragmentation of dipyridamole and its rapid and sensitive liquid chromatography/electrospray ionisation tandem mass spectrometric determination in human plasma. Rapid Communications in Mass Spectrometry 2008; 22: 511-518.
249. Yawney J, Treacy S, Hindmarsh KW and Burczynski FJ. A general screening method for acidic, neutral, and basic drugs in whole blood using the Oasis MCX® column. Journal of Analytical Toxicology 2002; 26: 325-332.
250. de Zeeuw RA. Substance identification: the weak link in analytical toxicology. Journal of Chromatography B 2004; 811: 3-12.
251. Zeng W, Fisher AL, Musson DG and Qui Wang A. High-throughput liquid chromatography for drug analysis in biological fluids: investigation of extraction column life. Journal of Chromatography B 2004; 806: 177-183.
252. Zhang G, Terry Jr AV and Bartlett MG. Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry. Biomedical Chromatography 2008; 22: 770-778.
253. Zhao JJ, Yang AY and Rogers JD. Effects of liquid chromatography mobile phase buffer contents on the ionisation and fragmentation of analytes in liquid chromatography/ionspray tandem mass spectrometric determination. Journal of Mass Spectrometry 2002; 37: 421-433.
254. Zhou S, Zhou H, Larson M, Miller DL, Mao D, Jiang X and Naidong W. High-throughput biological sample analysis using on-line turbulent flow extraction combined with monolithic column liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2005; 19: 2144-2150.